Publication | Closed Access

Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

Renal Transplant PatientsUrologyTransplantationKidney TransplantCytomegalovirus-associated MorbidityKidney TransplantationImmunologyGraft SurvivalDeferred TherapyImmunotherapyMedicineCell TransplantationGraft Rejection